Androgen receptor blockade resistance with enzalutamide in prostate cancer results in immunosuppressive alterations in the tumor immune microenvironment

Pengfei Xu(University of California, Davis), Chengfei Liu(University of California, Davis)
Journal for ImmunoTherapy of Cancer
May 1, 2023
Cited by 64


Related Papers